| P50 | author | Diana Klakotskaia | Q87046069 |
| | Yuksel Agca | Q87843312 |
| P2093 | author name string | Todd R Schachtman | |
| | Edward G Stopa | |
| | Yuksel Agca | |
| | Rachel A Richardson | |
| P2860 | cites work | Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease | Q24682442 |
| | Homeostatic capabilities of the choroid plexus epithelium in Alzheimer's disease | Q24798001 |
| | Fiji: an open-source platform for biological-image analysis | Q27860912 |
| | Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction | Q29547778 |
| | Are the dorsal and ventral hippocampus functionally distinct structures? | Q29619734 |
| | BACE1: the beta-secretase enzyme in Alzheimer's disease | Q33202614 |
| | Development of transgenic rats producing human beta-amyloid precursor protein as a model for Alzheimer's disease: transgene and endogenous APP genes are regulated tissue-specifically | Q33321335 |
| | Early neurovascular dysfunction in a transgenic rat model of Alzheimer's disease | Q33555571 |
| | Cerebral amyloid angiopathy: accumulation of A beta in interstitial fluid drainage pathways in Alzheimer's disease | Q33922686 |
| | Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. | Q34341174 |
| | Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease | Q34520661 |
| | Neuroinflammation and neuronal loss precede Aβ plaque deposition in the hAPP-J20 mouse model of Alzheimer's disease. | Q34656208 |
| | A shortened Barnes maze protocol reveals memory deficits at 4-months of age in the triple-transgenic mouse model of Alzheimer's disease | Q35043942 |
| | Alzheimer's disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis | Q35183975 |
| | Cerebral amyloid angiopathy in traumatic brain injury: association with apolipoprotein E genotype | Q35486023 |
| | Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons. | Q35745836 |
| | Role of Liver X Receptor in AD Pathophysiology. | Q35882575 |
| | A behavioral assessment of hippocampal function based on a subregional analysis | Q35969734 |
| | Presenilin 1 transgene addition to amyloid precursor protein overexpressing transgenic rats increases amyloid beta 42 levels and results in loss of memory retention. | Q36070202 |
| | [Hippocampal and cognitive alterations precede amyloid deposition in a mouse model for Alzheimer's disease]. | Q50782883 |
| | Gender, sex steroid hormones, and Alzheimer's disease. | Q36146996 |
| | Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms. | Q36260752 |
| | A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric aβ, and frank neuronal loss | Q37037738 |
| | Microvasculature changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy. | Q37398713 |
| | Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease | Q37613107 |
| | Which memory task for my mouse? A systematic review of spatial memory performance in the Tg2576 Alzheimer's mouse model | Q37874061 |
| | Memory deficits associated with senescence: A neurophysiological and behavioral study in the rat | Q40232008 |
| | Cerebral microvascular alterations in aging, leukoaraiosis, and Alzheimer's disease | Q41611048 |
| | Suppression of glymphatic fluid transport in a mouse model of Alzheimer's disease | Q42364356 |
| | Kaolin-induced chronic hydrocephalus accelerates amyloid deposition and vascular disease in transgenic rats expressing high levels of human APP. | Q43074615 |
| | Amyloid-beta(25-35)-induced memory impairments correlate with cell loss in rat hippocampus | Q44776973 |
| | Understanding white matter disease: imaging-pathological correlations in vascular cognitive impairment | Q45007669 |
| | Cognitive and emotional alterations in young Alzheimer's disease (3xTgAD) mice: effects of neonatal handling stimulation and sexual dimorphism | Q47703872 |
| | Early detection of cognitive deficits in the 3xTg-AD mouse model of Alzheimer's disease. | Q47712319 |
| | Beneficial effects of dietary EGCG and voluntary exercise on behavior in an Alzheimer's disease mouse model | Q47799205 |
| | Environmental enrichment eliminates the anxiety phenotypes in a triple transgenic mouse model of Alzheimer's disease | Q47803101 |
| | Visuo-spatial learning and memory deficits on the Barnes maze in the 16-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease | Q47842990 |
| | Spatial learning and memory impairment and increased locomotion in a transgenic amyloid precursor protein mouse model of Alzheimer's disease. | Q48145768 |
| | Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 2. Behavioral and cognitive changes | Q48161518 |
| | Impaired spatial learning in the APPSwe + PSEN1DeltaE9 bigenic mouse model of Alzheimer's disease. | Q48306292 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cerebral amyloid angiopathy | Q191562 |
| P304 | page(s) | e0195469 | |
| P577 | publication date | 2018-04-11 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Memory deficiency, cerebral amyloid angiopathy, and amyloid-β plaques in APP+PS1 double transgenic rat model of Alzheimer's disease. | |
| P478 | volume | 13 | |